• Explore /
  • Poster
  • / Health-related quality of life (HRQoL) for patients with advanced/metastatic urothelial carcinoma (UC) enrolled in KEYNOTE-052 who are potentially platinum ineligible.

Health-related quality of life (HRQoL) for patients with advanced/metastatic urothelial carcinoma (UC) enrolled in KEYNOTE-052 who are potentially platinum ineligible.

Abstract Poster

Authors

Rafael Morales-Barrera, Sr

Rafael Morales-Barrera

Vall d’Hebron Institute of Oncology, Vall d’Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain

Rafael Morales-Barrera , Daniel E. Castellano , Peter H. O'Donnell , Petros Grivas , Jacqueline Vuky , Thomas Powles , Kylea R. Potvin , Susanna Y. Cheng , Eli Rosenbaum , Noah M. Hahn , Daniel Keizman , Fausto Roila , Jose Luis Perez-Gracia , Elizabeth R. Plimack , Ronald De Wit , Jin Zhi Xu , Kentaro Imai , Haojie Li , Josephine M. Norquist , Joaquim Bellmunt

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Genitourinary Cancer—Kidney and Bladder

Track

Genitourinary Cancer—Kidney and Bladder

Sub Track

Urothelial Cancer - Advanced/Metastatic Disease

Clinical Trial Registration Number

NCT02335424

Citation

J Clin Oncol 40, 2022 (suppl 16; abstr 4561)

DOI

10.1200/JCO.2022.40.16_suppl.4561

Abstract #

4561

Poster Bd #

52

Abstract Disclosures

Similar Posters

First Author: Jacqueline Vuky

First Author: Arjun Vasant Balar

First Author: Peter H. O'Donnell

First Author: Thomas Powles